Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies

Hirohiko Kakizaki1, Yasuhiro Takahashi1, Masayoshi Iwaki1, Akihiro Ichinose2, Dinesh Selva3, Igal Leibovitch41Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Plastic Surgery, Kobe University, Chuo, Kobe, Hyogo, Japan; 3South Australian Institute of Ophth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hirohiko Kakizaki, Yasuhiro Takahashi, Masayoshi Iwaki, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/f17cbc77fc6e4432998c2b70f9c9d128
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f17cbc77fc6e4432998c2b70f9c9d128
record_format dspace
spelling oai:doaj.org-article:f17cbc77fc6e4432998c2b70f9c9d1282021-12-02T03:40:13ZDouble motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies1177-54671177-5483https://doaj.org/article/f17cbc77fc6e4432998c2b70f9c9d1282011-03-01T00:00:00Zhttp://www.dovepress.com/double-motion-of-upper-eyelids-in-gravesrsquo-orbitopathy-an-additiona-a6559https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Hirohiko Kakizaki1, Yasuhiro Takahashi1, Masayoshi Iwaki1, Akihiro Ichinose2, Dinesh Selva3, Igal Leibovitch41Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Plastic Surgery, Kobe University, Chuo, Kobe, Hyogo, Japan; 3South Australian Institute of Ophthalmology and Discipline of Ophthalmology and Visual Sciences, University of Adelaide, South Australia, Australia; 4Division of Oculoplastic and Orbital Surgery, Department of Ophthalmology, Tel-Aviv Medical Center, Tel-Aviv University, Tel-Aviv, IsraelPurpose: To assess the effectiveness of the upper eyelid double motion sign in Graves’ orbitopathy (GO) in detecting thyroid dysfunction or a positive level of thyroid-related autoantibodies.Methods: GO was defined when more than two GO-related eyelid symptoms, including the double motion sign, existed with at least one positive thyroid-related blood test. Blood tests were performed in patients with more than two GO-related eyelid symptoms. The double motion was defined when the upper eyelid stopped at least once during downward eye movement. Fifty patients without GO or other eyelid diseases were used as controls.Results: There were 353 patients who showed more than two GO-related eyelid symptoms including the upper eyelid double motion sign. Of these, 300 patients were diagnosed with GO (300/353, 85.0%). The double motion sign was demonstrated in 267 patients (75.6%). A pause in double motion was typically seen around the anterosuperior direction of gaze. Double motion was not seen in any of the control eyelids. Although only 7.0% were hyperthyroid and 8.6% were hypothyroid, thyroid related autoantibodies were shown in 73.9% of patients. When the double motion sign was removed from the diagnostic criteria of GO, 263 patients had more than two thyroid-related eyelid symptoms, including 223 patients diagnosed as GO (25.7% reduction), although the rate of a correct diagnosis was almost the same (84.8%).Conclusions: The double motion sign of the upper eyelids is frequently demonstrated in GO patients. This previously unreported sign can help in detecting thyroid dysfunction states with positive levels of autoantibodies.Keywords: GO, self-antibody Hirohiko KakizakiYasuhiro TakahashiMasayoshi Iwakiet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 327-330 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Hirohiko Kakizaki
Yasuhiro Takahashi
Masayoshi Iwaki
et al
Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
description Hirohiko Kakizaki1, Yasuhiro Takahashi1, Masayoshi Iwaki1, Akihiro Ichinose2, Dinesh Selva3, Igal Leibovitch41Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Plastic Surgery, Kobe University, Chuo, Kobe, Hyogo, Japan; 3South Australian Institute of Ophthalmology and Discipline of Ophthalmology and Visual Sciences, University of Adelaide, South Australia, Australia; 4Division of Oculoplastic and Orbital Surgery, Department of Ophthalmology, Tel-Aviv Medical Center, Tel-Aviv University, Tel-Aviv, IsraelPurpose: To assess the effectiveness of the upper eyelid double motion sign in Graves’ orbitopathy (GO) in detecting thyroid dysfunction or a positive level of thyroid-related autoantibodies.Methods: GO was defined when more than two GO-related eyelid symptoms, including the double motion sign, existed with at least one positive thyroid-related blood test. Blood tests were performed in patients with more than two GO-related eyelid symptoms. The double motion was defined when the upper eyelid stopped at least once during downward eye movement. Fifty patients without GO or other eyelid diseases were used as controls.Results: There were 353 patients who showed more than two GO-related eyelid symptoms including the upper eyelid double motion sign. Of these, 300 patients were diagnosed with GO (300/353, 85.0%). The double motion sign was demonstrated in 267 patients (75.6%). A pause in double motion was typically seen around the anterosuperior direction of gaze. Double motion was not seen in any of the control eyelids. Although only 7.0% were hyperthyroid and 8.6% were hypothyroid, thyroid related autoantibodies were shown in 73.9% of patients. When the double motion sign was removed from the diagnostic criteria of GO, 263 patients had more than two thyroid-related eyelid symptoms, including 223 patients diagnosed as GO (25.7% reduction), although the rate of a correct diagnosis was almost the same (84.8%).Conclusions: The double motion sign of the upper eyelids is frequently demonstrated in GO patients. This previously unreported sign can help in detecting thyroid dysfunction states with positive levels of autoantibodies.Keywords: GO, self-antibody
format article
author Hirohiko Kakizaki
Yasuhiro Takahashi
Masayoshi Iwaki
et al
author_facet Hirohiko Kakizaki
Yasuhiro Takahashi
Masayoshi Iwaki
et al
author_sort Hirohiko Kakizaki
title Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
title_short Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
title_full Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
title_fullStr Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
title_full_unstemmed Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
title_sort double motion of upper eyelids in graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/f17cbc77fc6e4432998c2b70f9c9d128
work_keys_str_mv AT hirohikokakizaki doublemotionofuppereyelidsingravesamprsquoorbitopathyanadditionalsignfordetectionofthyroiddysfunctionorpositivethyroidautoantibodies
AT yasuhirotakahashi doublemotionofuppereyelidsingravesamprsquoorbitopathyanadditionalsignfordetectionofthyroiddysfunctionorpositivethyroidautoantibodies
AT masayoshiiwaki doublemotionofuppereyelidsingravesamprsquoorbitopathyanadditionalsignfordetectionofthyroiddysfunctionorpositivethyroidautoantibodies
AT etal doublemotionofuppereyelidsingravesamprsquoorbitopathyanadditionalsignfordetectionofthyroiddysfunctionorpositivethyroidautoantibodies
_version_ 1718401707172429824